Cite
Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs.
MLA
Berte, Nancy, et al. “Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs.” Molecular Cancer Therapeutics, vol. 15, no. 11, Nov. 2016, pp. 2665–78. EBSCOhost, https://doi.org/10.1158/1535-7163.MCT-16-0176.
APA
Berte, N., Piée-Staffa, A., Piecha, N., Wang, M., Borgmann, K., Kaina, B., & Nikolova, T. (2016). Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs. Molecular Cancer Therapeutics, 15(11), 2665–2678. https://doi.org/10.1158/1535-7163.MCT-16-0176
Chicago
Berte, Nancy, Andrea Piée-Staffa, Nadine Piecha, Mengwan Wang, Kerstin Borgmann, Bernd Kaina, and Teodora Nikolova. 2016. “Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs.” Molecular Cancer Therapeutics 15 (11): 2665–78. doi:10.1158/1535-7163.MCT-16-0176.